Bristol-Myers Squibb Company

09/27/2021 | Press release | Distributed by Public on 09/27/2021 05:13

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy for Unresectable Advanced,[...]